Page last updated: 2024-11-05

styrene glycol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

styrene glycol: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7149
CHEMBL ID3188703
CHEBI ID183269
SCHEMBL ID24750
MeSH IDM0098869

Synonyms (71)

Synonym
CHEBI:183269
1,2-ethanediol, 1-phenyl-
1-phenylethylene glycol
einecs 202-258-1
ai3-03789
fenylglycol [czech]
phenyl glycol ether
1,2-dihydroxyethylbenzene
nsc 406601
1,2-ethanediol, phenyl-
alpha,beta-dihydroxyethylbenzene
brn 1306723
phenylethane-1,2-diol
1-fenyl-1,2-ethandiol [czech]
1-phenylethane-1,2-diol
phenyl-1,2-ethanediol
93-56-1
styrene glycol
nsc-406601
1,2-dihydroxy-1-phenylethane
styrolyl alcohol
1-phenyl-1,2-ethanediol
phenylethylene glycol
phenyl glycol
nsc406601
.alpha.,.beta.-dihydroxyethylbenzene
phenylethanediol
1-phenyl-1,2-ethanediol, 97%
NCIOPEN2_003573
1-phenyl-1
P0686
A844633
AKOS004903345
4-06-00-05939 (beilstein handbook reference)
1-fenyl-1,2-ethandiol
fenylglycol
unii-2zac511uk8
2zac511uk8 ,
tox21_302040
NCGC00255814-01
cas-93-56-1
dtxsid8042422 ,
dtxcid6022422
1-phenyl-ethane-1,2-diol
FT-0605073
FT-0604449
FT-0605276
(+/-)-styrene glycol
1,2-dihydroxy-2-phenylethane
styrene glycol [mi]
styrene glycol, (+/-)-
SCHEMBL24750
alpha-(hydroxymethyl)benzylalcohol
2-phenyl-2-hydroxyethanol
(+/-)-1-phenyl-1,2-ethanediol
alpha-(hydroxymethyl)benzyl alcohol
SY017542
SY017543
FD10472
CHEMBL3188703
7138-28-5
mfcd00003546
CS-W016504
FT-0674673
Q26841299
AS-11660
EN300-111545
SB44621
SB44462
HY-W015788
SY049723

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency38.89523.189029.884159.4836AID1224846
retinoid X nuclear receptor alphaHomo sapiens (human)Potency43.64120.000817.505159.3239AID1159527
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency2.75360.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1490958Cytotoxicity against human HT-29 cells after 3 days by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Halogenated Compounds from Directed Fermentation of Penicillium concentricum, an Endophytic Fungus of the Liverwort Trichocolea tomentella.
AID1490957Cytotoxicity against human MCF7 cells after 3 days by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Halogenated Compounds from Directed Fermentation of Penicillium concentricum, an Endophytic Fungus of the Liverwort Trichocolea tomentella.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (19.44)18.7374
1990's13 (18.06)18.2507
2000's16 (22.22)29.6817
2010's26 (36.11)24.3611
2020's3 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.01 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (98.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]